Gateway 2011: Labconco Corporation - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Gateway 2011: Labconco Corporation



Your online Gateway to Labconco Corporation in 2011

8811 Prospect Avenue
Kansas City, MO 64132
800-821-5525/816-333-8811
Fax: 816-363-0130
www.labconco.com

Labconco has been manufacturing laboratory equipment since 1925. We sell through a worldwide network of laboratory supply distributors. Our laboratory equipment is marketed to pharmaceutical, industrial, life science, environmental, clinical and crime laboratories. The wide variety of products include biological safety cabinets, fume hoods, glove boxes, glassware washers, freeze dry systems, carbon-filtered enclosures, balance enclosures, bulk powder enclosures, laboratory animal research enclosures, evaporation systems and centrifugal concentrators. Three of Labconco’s major product lines contribute toward LEED credits: fume hoods, biosafety cabinets, and glassware washers. Labconco is ISO 9001 certified and is a member of the USGBC.

<

Protector® Filtered Glove Boxes provide inlet and outlet HEPA or ULPA filtration and a leak-tight physical barrier to protect the operator from exposure to potentially hazardous materials. 

The FreeZone® -105°C 4.5 Liter Benchtop Freeze Dry Systems have ice holding capacity for light to moderate loads and have dual refrigeration systems for samples with very low eutectic points.

 

New Products
and Releases
New Whitepapers

FreeZone® -105°C 4.5 Liter Benchtop Freeze Dry Systems

New -105˚C FreeZone® Freeze Dry System
  NEW Protector® Glove Boxes
   



ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality

Click here